Primary Vitrectomy With Silicone Oil or SF6 for Rhegmatogenous Retinal Detachment
NCT05377606 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62
Last updated 2023-08-31
Summary
Rhegmatogenous retinal detachment (RRD) is the separation of the neurosensory retina from the retinal pigment epithelium caused by the presence of a break that leads to the passage of fluid from the vitreous cavity into the potential subretinal space. It is a sight threatening disease, affecting largely people 50 years or older, with an annual incidence varying between 6.3 and 17.9 people per 100,000 population, and is unfortunately increasing. Although other surgical options do exist for the repair of primary RRD, pars plana vitrectomy (PPV) has clear advantages and is certainly effective in the treatment of these patients.
Several agents are used for intraocular tamponade following PPV for RRD. These agents are either silicone oil (SO) or gases like air, perfluoropropane (C3F8), sulfur hexafluoride (SF6), or perfluoroethane (C2F6).
In addition to the complications uniquely peculiar to using SO, research has found out that a reduction in retinal sensitivity on microperimetry was greater in SO tamponade in comparison with gas, as well as poorer visual outcome, microvasculature damage and affection of retinal layers including ganglion cell complex (GCC) in the SO group.
Even though many studies were done to compare between SO and intraocular gas tamponades with respect to many aspects, only one study compared the effects SO had on macular vasculature and anatomy in comparison with air and no study at all to date has compared the SO to SF6 gas in terms of retinal vascular changes, correlating them to thinning of GCC and macular sensitivity, which is precisely the main aim of the current study.
Conditions
- Rhegmatogenous Retinal Detachment
- Primary Vitrectomy
Interventions
- PROCEDURE
-
Pars plana vitrectomy with silicone oil
Silicone oil will be used at the end of primary vitrectomy. OCT, OCTA and microperimetry will be done 2 months later. Silicone oil will be removed at 3 months. Finally, the OCT, OCTA, and microperimetry will be repeated once more after 4 months from the vitrectomy.
- PROCEDURE
-
Pars plana vitrectomy with SF6
Sulfur hexafluoride (SF6) will be used at the end of primary vitrectomy. OCT, OCTA, and microperimetry will be done 2 months and 4 months after surgery.
Sponsors & Collaborators
-
Cairo University
lead OTHER
Principal Investigators
-
Mina S. Abdelmalak, MSc · Cairo University
-
Soheir M. Mahmoud, PhD · Cairo University
-
Ahmed A. Abdel Kader, PhD · Cairo University
-
Asmaa M. Shuaib, PhD · Cairo University
-
Ayman G. Elnahry, PhD · Cairo University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-23
- Primary Completion
- 2023-03-08
- Completion
- 2023-05-08
Countries
- Egypt
Study Locations
More Related Trials
-
Internal Limiting Membrane Peeling in Retinal Detachment Surgery
NCT05538156 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
NCT02858076 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Duration of Silicone Oil Tamponade on Foveal and Parafoveal Thickness in Rhegmatogenous Retinal Detachment
NCT05817630 ·Status: COMPLETED
-
Treatment of Retinal Detachment in People Who Have Not Had Cataract Surgery With Vitrectomy vs Vitrectomy and Cataract Removal
NCT06997874 ·Status: RECRUITING ·Phase: PHASE3
-
Functional and Morphological Results of Rhegmatogenous Retinal Detachment Treated With Vitrectomy
NCT03902795 ·Status: COMPLETED
-
Suprachoroidal Buckling for the Management of Rhegmatogenous Retinal Detachment
NCT04518696 ·Status: UNKNOWN ·Phase: NA
-
REtinal Detachment Outcomes Study
NCT05863312 ·Status: RECRUITING ·Phase: NA
-
Multi-electrocoagulation Retinectomy for Retinal Re-detachment in Silicone Oil Filled Eye
NCT02201706 ·Status: UNKNOWN ·Phase: NA
-
Influence of Perfluorocarbon Liquid (LIQUID) During Pars Plana Vitrectomy on Retinal Vessel Displacement in Primary Macula-involving Rhegmatogenous Retinal Detachment
NCT07027098 ·Status: RECRUITING ·Phase: NA
-
Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy
NCT03660384 ·Status: COMPLETED ·Phase: NA
-
Suprachoroidal Visco-buckling for the Treatment of Rhegmatogenous Retinal Detachment
NCT04557527 ·Status: COMPLETED ·Phase: NA
-
Study of Vitreoretinal Molecular Changes During Rhegmatogenous Retinal Detachment
NCT06347302 ·Status: COMPLETED ·Phase: NA
-
Vitreous Inflammation in Standard and Heavy Silicone Oil
NCT02675543 ·Status: COMPLETED ·Phase: NA
-
Primary Vitrectomy for the Treatment of Retinal Detachment in Highly Myopic
NCT01480505 ·Status: COMPLETED
-
Evaluation of Visual Functions After Pars Plana Vitrectomy With and Without Internal Limiting Membrane Peeling in RRD
NCT04139811 ·Status: COMPLETED ·Phase: NA
-
Foldable Capsular Scleral Buckling Versus Vitrectomy in Medium-complex Rhegmatogenous Retinal Detachment Treatment
NCT06610786 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Double Retinal Tamponade for Retinal Detachment With PVR and Inferior Breaks.
NCT04168255 ·Status: COMPLETED ·Phase: NA
-
Air Tamponade Versus Fluorinated Gas Tamponade for Rhegmatogenous Retinal Detachment
NCT07034469 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Air Versus Gas Tamponade in Primary Retinal Detachment
NCT05561569 ·Status: UNKNOWN ·Phase: NA
-
Quantification of Silicone Oil Emulsification After Pars Plana Vitrectomy
NCT04774146 ·Status: UNKNOWN
-
Healaflow Patch for the Treatment of Rhegmatogenous Retinal Detachment
NCT03542162 ·Status: COMPLETED ·Phase: NA
-
Redetachment Under Densiron for RD Multiple Breaks
NCT05716971 ·Status: COMPLETED
-
Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy
NCT05523869 ·Status: RECRUITING ·Phase: PHASE2
-
Partial Posterior Hyaloidectomy in Macular Surgery
NCT01454466 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Higher Cutting Rate in Microincision Vitrectomy for Proliferative Diabetic Retinopathy
NCT02464800 ·Status: COMPLETED